Sterling Pharma SolutionsSterling Pharma Solutions is a global contract development and manufacturing organisation (CDMO) with more than 50 years' experience in providing small molecule API, as well as Antibody Drug Conjugate (ADC), development and manufacturing services to the pharmaceutical industry, specialising in handling challenging chemistries. Sterling has five facilities employing 1,350+ people: its HQ in Cramlington, UK and a facility in Ringaskiddy, Ireland; two sites in the US, in North Carolina and Wisconsin; and a dedicated bioconjugation facility in Deeside, Wales.
